Juul Labs has taken another important step in its path forward to introduce novel technologies that provide adult smokers an alternative to combustible cigarettes…
Juul Labs today announced the submission of the first Premarket Tobacco Product Application (PMTA) for the company’s next-generation vapor platform to the U.S. Food and Drug Administration (FDA).
Juul Labs today announced that it received notice from the Food and Drug Administration (FDA) that the company’s Premarket Tobacco Product Applications (PMTA) will enter the substantive review phase.
We are fully committed to the current PMTA process and are confident in the content and quality of the materials we will submit with our application by…
This week, Juul Labs Chief Regulatory Officer, Joe Murillo, delivered remarks at the 76th Tobacco Science Research Conference, where he discussed the current state…
Today, JLI is announcing a company restructuring aimed at reducing our operating costs and positioning us to continue to advance our mission during a…
Resolution of issues from the company’s past and its historical legal challenges has remained a critical priority to secure certainty for our future. While…
This settlement with seven state attorneys general represents another critical part in our ongoing commitment to resolve issues from the company’s past. The terms…
Today, Juul Labs, Inc. (JLI) posted its administrative appeal of the marketing denial order (MDO) issued by the Food and Drug Administration (FDA), which…
Joe Murillo delivers keynote remarks at the Global Tobacco & Nicotine Forum 2022.